findmyKOL
Clinical trialNCT06224270WithdrawnPhase 4Interventional

Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications

SponsorUniversity of Wisconsin, MadisonEnrollment0IBDInflammatory Bowel Diseases
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This multi-center study will evaluate the safety and immune response to recombinant zoster vaccine (RZV) series in 264 patients with inflammatory bowel disease (IBD) on immunosuppressive therapy recruited from 6 study sites who can expect to be on study for up to 14 months.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Jacksonville, Florida, United States

  • Mercy Medical Center

    Baltimore, Maryland, United States

  • New York University

    New York, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • Uw Hospital and Clinics

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Adjuvanted Recombinant Zoster Vaccine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2024
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
25 Sept 2024
Registered enrollment
0
Registry id
NCT06224270

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.